Exploiting the stress response to detonate mitochondria in cancer cells
Tuesday, April 19, 2011 - 16:31
in Health & Medicine
Researchers at The Wistar Institute have found a new way to force cancer cells to self-destruct. Low doses of one anti-cancer drug currently in development, called Gamitrinib, sensitize tumor cells to a second drug, called TRAIL, also currently in clinical development as part of an anticancer regimen.